Myeloid Leukemias Active Not Recruiting Phase 3 Trials for Enasidenib (DB13874)

Back to Myeloid Leukemias

Also known as: Leukemia, Myeloid / Myeloid leukaemia / Myeloid Leukemia / Leukemia myeloid / Non-lymphoblastic leukaemia NOS / Leukemic granulocytic / Non-lymphoblastic leukemia NOS / Unspecified myeloid leukaemia / Unspecified myeloid leukemia / Leukaemia myelogenous / Leukemia myelogenous / Myelocytic leukaemia / Myelocytic leukemia / Leukemia granulocytic NOS / Leukaemia granulocytic NOS / Leukaemia granulocytic / Leukemia granulocytic / Leukaemia myeloid / Myeloid leukemia NOS / Myeloid leukaemia NOS

Indication	Status	Phase
DBCOND0042450 (Myeloid Leukemias)	Active Not Recruiting	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02577406	An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation	Treatment	Azacitidine (DB00928) Cytarabine (DB00987) Enasidenib (DB13874)